Prenetics Global Ltd (PRE)
Official siteCONSUMER DEFENSIVE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $322.18M
Last updated: Nov 17, 2026 at 4:10 PM ET
Prenetics Global Ltd (PRE) Statistics
Prenetics Global (PRE) has a market cap of $322.18M. Revenue grew 207.00% over the last 12 months from the 12 months before. Its share count is up 30.34% from a year earlier.
Total Valuation
| Market Cap | $322.18M |
|---|---|
| Latest price (Nov 17, 2026) | $16.33 |
Key Dates
The next earnings report is expected on Feb 16, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 16, 2027 (expected) |
|---|---|
| Last Earnings Date | Aug 18, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 2.0x and 3.0x. Its year-end P/S ranged from 2.4x to 3.0x from 2023 to 2025.
| P/S Ratio | 2.0x |
|---|---|
| Forward P/S | 1.4x |
| P/B Ratio | 3.0x |
| P/TBV Ratio | 3.0x |
Price Statistics
The stock is up 33.85% over 52 weeks and trades 18.68% below its 50-day average.
| Beta (1Y) | 1.56 |
|---|---|
| 52-Week Change | +33.85% |
| 1-Month Change | -14.14% |
| 3-Month Change | -12.95% |
| 6-Month Change | +11.73% |
| Total Return (1Y) | +33.85% |
| Total Return (3Y CAGR) | +52.20% |
| Return vs SPY (1Y) | +21.04% |
| Max Drawdown (1Y) | -41.03% |
| Max Drawdown (3Y) | -51.33% |
| Sharpe Ratio (1Y) | 0.36 |
| Correlation with SPY (1Y) | 0.27 |
| 50-Day Average | $20.08 |
| 200-Day Average | $19.50 |
| 52-Week Range | $11.97 to $27.24 |
| RSI (14 Days) | 40.9 |
| Average Volume (20 Days) | 182.95K |
Financial Position
Current assets cover 4.04x current liabilities.
| Current Ratio | 4.04x |
|---|---|
| Quick Ratio | 3.66x |
| Interest Coverage | -546.51x |
Returns and Efficiency
Return on equity is -72.69% and return on assets is -44.00% over the last 12 months.
| Return on Equity (ROE) | -72.69% |
|---|---|
| Return on Assets (ROA) | -44.00% |
| Return on Capital Employed (ROCE) | -56.94% |
| ROA (5Y Average) | -48.62% |
| ROIC (5Y Average) | -23.09% |
| Asset Turnover | 0.81x |
| Inventory Turnover | 3.78x |
| Receivables Turnover | 16.77x |
| Cash Conversion Cycle | 108 days |
Scores
PRE has an Altman Z-Score of 3.15, in the safe zone above 2.99, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 3.15 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 5 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue was $142.56M over the last 12 months.
| Revenue | $142.56M |
|---|---|
| Revenue Growth (YoY) | +207.00% |
| Gross Profit | $89.25M |
| Operating Income | -$50.18M |
| Pretax Income | -$71.54M |
| Net Income | -$67.61M |
| EBIT | -$66.67M |
| Reported EPS (TTM) | -$1.89 |
Trailing 12 months through Jun 30, 2026.
Balance Sheet
Shareholder equity funds 60.53% of the $153.66M in total assets.
| Cash and Equivalents | $59.05M |
|---|---|
| Working Capital | $111.12M |
| Shareholder Equity | $93.01M |
| Book Value Per Share | $5.39 |
| Tangible Book Value | $92.99M |
| Tangible Book Per Share | $5.39 |
| Total Assets | $153.66M |
| Total Liabilities | $60.73M |
Balance sheet as of Jun 30, 2026.
Cash Flow
| Capital Expenditures | $15.87M |
|---|---|
| FCF Per Share | -$3.93 |
Trailing 12 months through Jun 30, 2026.
Margins
The operating margin is -35.20%.
| Gross Margin | 62.61% |
|---|---|
| Operating Margin | -35.20% |
| Pretax Margin | -50.18% |
| Net Margin | -47.43% |
| EBIT Margin | -46.77% |
| Gross Margin (5Y Average) | 39.99% |
Growth
Revenue grew 91.46% a year over 3 years.
| Revenue Growth (3Y CAGR) | +91.46% |
|---|---|
| Revenue Growth (5Y CAGR) | +7.23% |
| Book Value Per Share Growth (2Y CAGR) | -20.04% |
| Tangible Book Per Share Growth (2Y CAGR) | -22.99% |
Stock Splits
The last split was a 1-for-15 reverse split on Nov 14, 2023.
| Last Split Date | Nov 14, 2023 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:15 |
Peer Position
Against 11 similar companies, PRE has the 5th highest P/S.
P/S RatioPeer median 0.6x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +6.21%
| P/S Ratio | 2.0x vs 0.6x median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | +207.00% vs +6.21% median |
Analyst Forecast
Consensus estimates put revenue growth at 109.75% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +109.75% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About PRE
What is PRE's market cap?
Prenetics Global has a market cap of $322.18M.
How many shares of PRE are outstanding?
Prenetics Global has 17.27M shares outstanding. The count is up 30.34% from a year earlier.
Does PRE pay a dividend?
No. Prenetics Global does not pay a dividend.
PRE pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors